Top 5 Small-Cap Stocks With Highest Upside Potential
In this article, we will look at the top 5 small-cap stocks with highest upside potential.
Global Blood Therapeutics Inc. (GBT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,732,502 | $119,253 | +13% | 0.67% |
| 2. | Deep Track Capital David Kroin | 3,646,690 | $116,512 | +59% | 7.65% |
| 3. | Perceptive Advisors Joseph Edelman | 3,015,054 | $96,331 | -23% | 3.01% |
| 4. | OrbiMed Advisors Samuel Isaly | 2,044,000 | $65,306 | +30% | 1.18% |
| 5. | Point72 Asset Management Steve Cohen | 1,524,485 | $48,707 | +66% | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.96 | 500 | Officer | 5,161 | 2021-05-10 | Filing | |
| $52.37 | 10,000 | Director | 31,428 | 2020-03-13 | Filing | |
| $38.00 | 175,000 | Large Shareholder | 4,889,066 | 2017-12-19 | Filing | |
| $20.00 | 25,000 | Officer | 25,000 | 2015-08-17 | Filing | |
| $22.36 | 1,000 | Officer | 1,500 | 2016-01-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.25 | 1,260 | Director | 9,112 | 2022-06-21 | Filing | |
| $27.24 | 1,908 | Director | 5,376 | 2022-06-21 | Filing | |
| $30.21 | 4,800 | Director | 3,037 | 2021-09-09 | Filing | |
| $36.54 | 1,609 | Director | 3,684 | 2021-06-18 | Filing | |
| $36.54 | 1,065 | Director | 6,772 | 2021-06-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 409,923 | $13,097,038 | 0% | |
| 2. | 103,138 | $3,295,259 | 0.02% | |
| 3. | 13,597 | $434,424 | 0% | |
| 4. | 6,019,431 | $192,321 | 0% | |
| 5. | 4,772,391 | $152,476 | 0% |
News See All
Thomas Steyer's Farallon Capital is Buying These 5 Stocks
In this article, we discuss 5 stocks that Thomas Steyer’s Farallon Capital is buying.
5 Best Small Cap Stocks To Buy for 2022
Global Ship Lease, Inc. (NYSE:GSL) is a London-based shipping company that leases containerships to companies at fixed rates.
Hedge Funds Are Coming Back To Global Blood Therapeutics Inc (GBT)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Funds Continue Dumping Global Blood Therapeutics Inc (GBT)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is GBT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
5 Best Biotech Stocks to Invest In
A clinical-stage biopharmaceutical company Global Blood Therapeutics, Inc. (NASDAQ: GBT) is the long-running investment of a billionaire hedge fund manager.
Hedge Funds Have Never Been This Bullish On Global Blood Therapeutics Inc (GBT)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Global Blood Therapeutics Inc (GBT) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Global Blood Therapeutics Inc (GBT): Hedge Funds In Wait-and-See Mode
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
